JESSICA RUBEL: Open Payments
NPI 1649897810 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 79 payments from 19 companies in 2025. Trend: 2023 $1,924 · 2024 $1,843 · 2025 $1,550
Food & beverage: $1,458Education: $92
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $180 |
| Novartis Pharmaceuticals Corporation | 8 | $180 |
| UCB, Inc. | 9 | $170 |
| Regeneron Healthcare Solutions, Inc. | 4 | $162 |
| Galderma Laboratories, L.P. | 12 | $141 |
| Amgen Inc. | 5 | $86 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $74 |
| ABBVIE INC. | 4 | $74 |
| Botanix SB Inc | 3 | $73 |
| Biofrontera Inc. | 4 | $71 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, COSENTYX, OTEZLA, SKYRIZI, SOFDRA, VTAMA.
Industry payments across AZ — which companies pay providers there.
